Collectively, these data show that sia-rDer p 2 inhibits TH2 cytokine production, especially IL-5, and may therefore be a good candidate for Der p 2–specific AIT or be used for prophylactic vaccination against Der p 2–HDM allergy. This evidence concerns the gene IL5 and allergic disease.